Jeremy M. Lawrence
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeremy M. Lawrence has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Sophie Breunig
Department of Psychology and Neuroscience, University of Colorado at Boulder, Boulder, USA
7 shared publications Andrew D. Grotzinger
Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO USA
5 shared publications- Andrew David Grotzinger
Department of Psychology and Neuroscience, University of Colorado at Boulder, Boulder, USA
4 shared publications Isabelle F. Foote
Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO, USA
3 shared publications- Isabelle Francesca Foote
Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, USA
3 shared publications Lukas S. Schaffer
Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO USA
3 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Springer Nature in Behavior Genetics
- p. 1
Correction: Uncovering the Role of Biological Sex in the Divergent Genetic Profiles of Early and Late-Diagnosed Autism
- 23 September 2026
- Published by Springer Nature in Behavior Genetics
- p. 1
Open AccessCorrection: Uncovering the Role of Biological Sex in the Divergent Genetic Profiles of Early and Late-Diagnosed Autism
- Open Access
- 27 August 2026
- Published by Springer Nature in Behavior Genetics
- p. 1-13
Uncovering the Role of Biological Sex in the Divergent Genetic Profiles of Early and Late-Diagnosed Autism
Autism is a neurodevelopmental disorder with a significant male prevalence bias. While recent evidence suggests that genetic heterogeneity is indexed by age at diagnosis, males are also typically diagnosed earlier, such that the extent to which these age-specific findings are confounded by shared genetic signal with sex-specific genetic architecture remains unclear. To test this, we leveraged sex- and age of diagnosis-stratified GWAS summary statistics for autism and applied a multiple regression framework within Genomic Structural Equation Modeling (Genomic SEM). This approach allowed us to disentangle the overlapping genetic variance between sex, diagnostic timing, and 68 clinically relevant phenotypes reflecting a host of different psychiatric, cognitive, health, and social outcomes. Consistent with prior findings, we identified significantly divergent genetic associations with external traits between early- and late-diagnosed autism subtypes. We also identified few findings for sex-specific associations, along with high genetic correlations across these two traits, which questions the biological basis for disproportionate prevalence rates in males. Multiple regression models confirmed that early-specific associations were not confounded by biological sex. Conversely, the correlations between late-diagnosed autism and the sex-stratified autism GWAS were near 1, indicating that late-specific associations may be confounded. Follow-up analyses using an internalizing factor provided support for sex differences in clinical presentation and age at diagnosis, with female-diagnosed and late-diagnosed autism estimated to have stronger genetic correlations with internalizing traits compared to male and early-diagnosed counterparts. This study underscores the importance of subtyping in genetic analyses and provides a framework to disentangle confounded genetic pathways.
- 27 August 2026
- Published by Springer Nature in Behavior Genetics
- p. 1-13
Open AccessUncovering the Role of Biological Sex in the Divergent Genetic Profiles of Early and Late-Diagnosed Autism
Autism is a neurodevelopmental disorder with a significant male prevalence bias. While recent evidence suggests that genetic heterogeneity is indexed by age at diagnosis, males are also typically diagnosed earlier, such that the extent to which these age-specific findings are confounded by shared genetic signal with sex-specific genetic architecture remains unclear. To test this, we leveraged sex- and age of diagnosis-stratified GWAS summary statistics for autism and applied a multiple regression framework within Genomic Structural Equation Modeling (Genomic SEM). This approach allowed us to disentangle the overlapping genetic variance between sex, diagnostic timing, and 68 clinically relevant phenotypes reflecting a host of different psychiatric, cognitive, health, and social outcomes. Consistent with prior findings, we identified significantly divergent genetic associations with external traits between early- and late-diagnosed autism subtypes. We also identified few findings for sex-specific associations, along with high genetic correlations across these two traits, which questions the biological basis for disproportionate prevalence rates in males. Multiple regression models confirmed that early-specific associations were not confounded by biological sex. Conversely, the correlations between late-diagnosed autism and the sex-stratified autism GWAS were near 1, indicating that late-specific associations may be confounded. Follow-up analyses using an internalizing factor provided support for sex differences in clinical presentation and age at diagnosis, with female-diagnosed and late-diagnosed autism estimated to have stronger genetic correlations with internalizing traits compared to male and early-diagnosed counterparts. This study underscores the importance of subtyping in genetic analyses and provides a framework to disentangle confounded genetic pathways.
- Open Access
Genetic Signal Augmentation of Childhood-Onset and Treatment-Resistant Major Depression Reveals Distinct Biological Disorders
Major depression (MD) is a disorder class that exhibits substantial phenotypic and clinical heterogeneity, yet many large-scale molecular genetic investigations treat MD as a unitary outcome. Here, we applied Genomic Structural Equation Modeling (Genomic SEM) to characterize the genetic variation in two clinically relevant MD subtypes, childhood-onset (child-onset) and treatment-resistant MD, that are independent of the field-standard GWAS of MD in all its forms. In addition, we fit a complementary “boosting” model that leveraged shared signal across the subtype and general MD GWAS to increase power for subtype biological discovery. At the genome-wide level, more than half of the common-variant liability for child-onset and treatment-resistant MD was unique relative to the general MD GWAS, indicating substantial subtype-specific genetic architecture. Unique components of both subtypes showed robust associations with genetic liability for schizophrenia and bipolar disorder, and the child-onset specific component exhibited genome-wide overlap with early developmental outcomes, including autism spectrum disorder and childhood intelligence. Transcriptome-wide analyses implicated upregulation of SMIM19 in liability specific to child-onset MD, while stratified functional enrichment highlighted gene sets involved in limbic and frontal brain systems for the boosted child-onset component. Together, these findings demonstrate that MD contains biologically distinct subtypes that exhibit etiological divergences more akin to separate disorders than subtypes within a concrete diagnostic framework. We find that stratifying MD by biologically distinguishable subtypes may be crucial for enhancing biological discovery and elucidating etiological pathways in molecular genetic studies of depression.
Open AccessGenetic Signal Augmentation of Childhood-Onset and Treatment-Resistant Major Depression Reveals Distinct Biological Disorders
Major depression (MD) is a disorder class that exhibits substantial phenotypic and clinical heterogeneity, yet many large-scale molecular genetic investigations treat MD as a unitary outcome. Here, we applied Genomic Structural Equation Modeling (Genomic SEM) to characterize the genetic variation in two clinically relevant MD subtypes, childhood-onset (child-onset) and treatment-resistant MD, that are independent of the field-standard GWAS of MD in all its forms. In addition, we fit a complementary “boosting” model that leveraged shared signal across the subtype and general MD GWAS to increase power for subtype biological discovery. At the genome-wide level, more than half of the common-variant liability for child-onset and treatment-resistant MD was unique relative to the general MD GWAS, indicating substantial subtype-specific genetic architecture. Unique components of both subtypes showed robust associations with genetic liability for schizophrenia and bipolar disorder, and the child-onset specific component exhibited genome-wide overlap with early developmental outcomes, including autism spectrum disorder and childhood intelligence. Transcriptome-wide analyses implicated upregulation of SMIM19 in liability specific to child-onset MD, while stratified functional enrichment highlighted gene sets involved in limbic and frontal brain systems for the boosted child-onset component. Together, these findings demonstrate that MD contains biologically distinct subtypes that exhibit etiological divergences more akin to separate disorders than subtypes within a concrete diagnostic framework. We find that stratifying MD by biologically distinguishable subtypes may be crucial for enhancing biological discovery and elucidating etiological pathways in molecular genetic studies of depression.
- Open Access
- 21 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Shared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature describes widespread psychiatric–physical comorbidity. However, the extent to which observed bivariate risk is transdiagnostic remains uncertain. We apply Genomic SEM and introduce Genomic E-SEM, an exploratory factor-analytic extension of Genomic SEM, here applied to 73 physical outcomes (~1.9 million cases) across eight medical domains. We then modeled latent physical illness factors alongside previously identified psychiatric factors. Thought/psychotic and compulsive factors exhibited few associations with physical illness factors. Conversely, internalizing, neurodevelopmental, and substance-use factors showed substantial genome-wide genetic correlations with all physical illness systems. Multivariate GWAS of a transdiagnostic physical illness factor, defined by 21 physical disorders, identified 27 genomic risk loci and exhibited substantial predictive validity in subsequent PheWAS. This transdiagnostic factor again exhibited substantial genome-wide genetic correlations with internalizing, neurodevelopmental, and substance-use factors. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and suggest the need for additional nosological frameworks.
- 21 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessShared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature describes widespread psychiatric–physical comorbidity. However, the extent to which observed bivariate risk is transdiagnostic remains uncertain. We apply Genomic SEM and introduce Genomic E-SEM, an exploratory factor-analytic extension of Genomic SEM, here applied to 73 physical outcomes (~1.9 million cases) across eight medical domains. We then modeled latent physical illness factors alongside previously identified psychiatric factors. Thought/psychotic and compulsive factors exhibited few associations with physical illness factors. Conversely, internalizing, neurodevelopmental, and substance-use factors showed substantial genome-wide genetic correlations with all physical illness systems. Multivariate GWAS of a transdiagnostic physical illness factor, defined by 21 physical disorders, identified 27 genomic risk loci and exhibited substantial predictive validity in subsequent PheWAS. This transdiagnostic factor again exhibited substantial genome-wide genetic correlations with internalizing, neurodevelopmental, and substance-use factors. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and suggest the need for additional nosological frameworks.
- Open Access
Shared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature has shown that there are extensive comorbidity patterns between psychiatric and physical illness. However, our understanding of the multivariate systems of relationships underlying these patterns is poorly understood. Using Genomic SEM and Genomic E-SEM, an extension for genomic exploratory factor analysis that we introduce and validate, we evaluate the extent to which latent genomic factors from eight domains, encompassing 76 physical outcomes across 1.9 million cases, evince genetic overlap with previously identified psychiatric factors. We find that internalizing, neurodevelopmental, and substance use factors are broadly associated with increased genetic risk sharing across all physical illness domains. Conversely, we find that a compulsive factor is protective against circulatory and metabolic illness, whereas genetic risk sharing between physical illness factors and psychotic/thought disorders was limited. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and call into question the bifurcation of psychiatric and physical conditions.
Open AccessShared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature has shown that there are extensive comorbidity patterns between psychiatric and physical illness. However, our understanding of the multivariate systems of relationships underlying these patterns is poorly understood. Using Genomic SEM and Genomic E-SEM, an extension for genomic exploratory factor analysis that we introduce and validate, we evaluate the extent to which latent genomic factors from eight domains, encompassing 76 physical outcomes across 1.9 million cases, evince genetic overlap with previously identified psychiatric factors. We find that internalizing, neurodevelopmental, and substance use factors are broadly associated with increased genetic risk sharing across all physical illness domains. Conversely, we find that a compulsive factor is protective against circulatory and metabolic illness, whereas genetic risk sharing between physical illness factors and psychotic/thought disorders was limited. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and call into question the bifurcation of psychiatric and physical conditions.
- Open Access
- 27 October 2023
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (6) , 1152-1159
Genomic SEM applied to explore etiological divergences in bipolar subtypes
Background: Bipolar disorder (BD) is an overarching diagnostic class defined by the presence of at least one prior manic episode (BD I) or both a prior hypomanic episode and a prior depressive episode (BD II). Traditionally, BD II has been conceptualized as a less severe presentation of BD I, however, extant literature to investigate this claim has been mixed.Methods: We apply genomic structural equation modeling (Genomic SEM) to investigate divergent genetic pathways across BD's two major subtypes using the most recent GWAS summary statistics from the PGC. We begin by identifying divergences in genetic correlations across 98 external traits using a Bonferroni-corrected threshold. We also use a theoretically informed follow-up model to examine the extent to which the genetic variance in each subtype is explained by schizophrenia and major depression. Lastly, transcriptome-wide SEM (T-SEM) was used to identify neuronal gene expression patterns associated with BD subtypes.Results: BD II was characterized by significantly larger genetic overlap across non-psychiatric medical and internalizing traits (e.g. heart disease, neuroticism, insomnia), while stronger associations for BD I were absent. Consistent with these findings, follow-up modeling revealed a substantial major depression component for BD II. T-SEM results revealed 35 unique genes associated with shared risk across BD subtypes.Conclusions: Divergent patterns of genetic relationships across external traits provide support for the distinction of the bipolar subtypes. However, our results also challenge the illness severity conceptualization of BD given stronger genetic overlap across BD II and a range of clinically relevant traits and disorders.
- 27 October 2023
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (6) , 1152-1159
Open AccessGenomic SEM applied to explore etiological divergences in bipolar subtypes
Background: Bipolar disorder (BD) is an overarching diagnostic class defined by the presence of at least one prior manic episode (BD I) or both a prior hypomanic episode and a prior depressive episode (BD II). Traditionally, BD II has been conceptualized as a less severe presentation of BD I, however, extant literature to investigate this claim has been mixed.Methods: We apply genomic structural equation modeling (Genomic SEM) to investigate divergent genetic pathways across BD's two major subtypes using the most recent GWAS summary statistics from the PGC. We begin by identifying divergences in genetic correlations across 98 external traits using a Bonferroni-corrected threshold. We also use a theoretically informed follow-up model to examine the extent to which the genetic variance in each subtype is explained by schizophrenia and major depression. Lastly, transcriptome-wide SEM (T-SEM) was used to identify neuronal gene expression patterns associated with BD subtypes.Results: BD II was characterized by significantly larger genetic overlap across non-psychiatric medical and internalizing traits (e.g. heart disease, neuroticism, insomnia), while stronger associations for BD I were absent. Consistent with these findings, follow-up modeling revealed a substantial major depression component for BD II. T-SEM results revealed 35 unique genes associated with shared risk across BD subtypes.Conclusions: Divergent patterns of genetic relationships across external traits provide support for the distinction of the bipolar subtypes. However, our results also challenge the illness severity conceptualization of BD given stronger genetic overlap across BD II and a range of clinically relevant traits and disorders.
- Open Access
Examining Differences in the Genetic and Functional Architecture of ADHD Diagnosed in Childhood and Adulthood
Background: Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that is diagnosed when symptoms onset in childhood. Here we investigate whether individuals who are diagnosed as children differ from those who are diagnosed in adulthood with respect to shared and unique architecture at the genome-wide, functional, and gene expression level of analysis. Methods: We utilize Genomic SEM to investigate the differences in genetic correlations of childhood and adulthood diagnosed ADHD with 98 behavioral, psychiatric, cognitive, and health outcomes. We go on to apply Stratified Genomic SEM and transcriptome-wide SEM (T-SEM) to identify functional annotations and patterns of gene expression associated with genetic risk sharing or divergence across the ADHD subgroups. Results: Relative to the childhood subgroup, adulthood diagnosed ADHD exhibited a significantly larger negative r g with educational attainment, the noncognitive skills of educational attainment, and age at first sexual intercourse. We also observe a larger positive r g for adulthood diagnosed ADHD with major depression, suicidal ideation, loneliness, and a latent internalizing factor. At the functional and gene expression levels, Stratified Genomic SEM and T-SEM analyses revealed three annotations and 22 genes, respectively, that were significantly associated with genetic risk sharing across the subtypes. Conclusion: This project demonstrates that ADHD diagnosed later in life shows much stronger genetic overlap with internalizing disorders and related traits, indicating the potential clinical relevance of distinguishing these subgroups. Given shared clinical features across internalizing disorders and ADHD (e.g., difficulty concentrating) one interpretation is that the internalizing spectrum is often misdiagnosed as ADHD in adulthood.
Open AccessExamining Differences in the Genetic and Functional Architecture of ADHD Diagnosed in Childhood and Adulthood
Background: Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that is diagnosed when symptoms onset in childhood. Here we investigate whether individuals who are diagnosed as children differ from those who are diagnosed in adulthood with respect to shared and unique architecture at the genome-wide, functional, and gene expression level of analysis. Methods: We utilize Genomic SEM to investigate the differences in genetic correlations of childhood and adulthood diagnosed ADHD with 98 behavioral, psychiatric, cognitive, and health outcomes. We go on to apply Stratified Genomic SEM and transcriptome-wide SEM (T-SEM) to identify functional annotations and patterns of gene expression associated with genetic risk sharing or divergence across the ADHD subgroups. Results: Relative to the childhood subgroup, adulthood diagnosed ADHD exhibited a significantly larger negative r g with educational attainment, the noncognitive skills of educational attainment, and age at first sexual intercourse. We also observe a larger positive r g for adulthood diagnosed ADHD with major depression, suicidal ideation, loneliness, and a latent internalizing factor. At the functional and gene expression levels, Stratified Genomic SEM and T-SEM analyses revealed three annotations and 22 genes, respectively, that were significantly associated with genetic risk sharing across the subtypes. Conclusion: This project demonstrates that ADHD diagnosed later in life shows much stronger genetic overlap with internalizing disorders and related traits, indicating the potential clinical relevance of distinguishing these subgroups. Given shared clinical features across internalizing disorders and ADHD (e.g., difficulty concentrating) one interpretation is that the internalizing spectrum is often misdiagnosed as ADHD in adulthood.
- Open Access
Genomic SEM Applied to Explore Etiological Divergences in Bipolar Subtypes
Background Bipolar Disorder (BD) is an overarching diagnostic class defined by the presence of at least one prior manic episode (BD I) or both a prior hypomanic episode and a prior depressive episode (BD II). Traditionally, BD II has been conceptualized as a less severe presentation of BD I, however, extant literature to investigate this claim has been mixed. Methods We apply Genomic Structural Equation Modeling (Genomic SEM) to investigate divergent genetic pathways across BD’s two major subtypes using the most recent GWAS summary statistics from the PGC. We begin by identifying divergences in genetic correlations across 89 external traits using a Bonferroni corrected threshold. We also use a theoretically informed follow-up model to examine the extent to which the genetic variance in each subtype is explained by schizophrenia and major depression. Lastly, Transcriptome-wide SEM (T-SEM) was used to identify gene expression patterns associated with the BD subtypes. Results BD II was characterized by significantly larger genetic overlap with internalizing traits (e.g., neuroticism, insomnia, physical inactivity), while significantly stronger associations for BD I were limited. Consistent with these findings, the follow-up model revealed a much larger major depression component for BD II. T-SEM results revealed 41 unique genes associated with risk pathways across BD subtypes. Conclusions Divergent patterns of genetic relationships across external traits provide support for the distinction of the bipolar subtypes. However, our results also challenge the illness severity conceptualization of BD given stronger genetic overlap across BD II and a range of clinically relevant traits and disorders.
Open AccessGenomic SEM Applied to Explore Etiological Divergences in Bipolar Subtypes
Background Bipolar Disorder (BD) is an overarching diagnostic class defined by the presence of at least one prior manic episode (BD I) or both a prior hypomanic episode and a prior depressive episode (BD II). Traditionally, BD II has been conceptualized as a less severe presentation of BD I, however, extant literature to investigate this claim has been mixed. Methods We apply Genomic Structural Equation Modeling (Genomic SEM) to investigate divergent genetic pathways across BD’s two major subtypes using the most recent GWAS summary statistics from the PGC. We begin by identifying divergences in genetic correlations across 89 external traits using a Bonferroni corrected threshold. We also use a theoretically informed follow-up model to examine the extent to which the genetic variance in each subtype is explained by schizophrenia and major depression. Lastly, Transcriptome-wide SEM (T-SEM) was used to identify gene expression patterns associated with the BD subtypes. Results BD II was characterized by significantly larger genetic overlap with internalizing traits (e.g., neuroticism, insomnia, physical inactivity), while significantly stronger associations for BD I were limited. Consistent with these findings, the follow-up model revealed a much larger major depression component for BD II. T-SEM results revealed 41 unique genes associated with risk pathways across BD subtypes. Conclusions Divergent patterns of genetic relationships across external traits provide support for the distinction of the bipolar subtypes. However, our results also challenge the illness severity conceptualization of BD given stronger genetic overlap across BD II and a range of clinically relevant traits and disorders.